Intercytex Group PLC - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Intercytex Group PLC. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Intercytex Group PLC. The Group's principal activity is researching, developing and commercialising cell-based therapies for the repair and regeneration of skin and hair. Products include Vavelta, a facial rejuvenation product intended to improve the appearance of facial imperfections. It is a suspension of human dermal fibroblasts in cell storage medium, for injection into the skin. In addition, the collagen secreted and remodelled by the human dermal fibroblasts will fill the pits created by acne scarring and to soften and reduce skin contractures caused by burns; SHEF-1, development of a stem cell line suitable for differentiation into retinal pigment epithelial (RPE) cells; ICX-SKN, being developed as a skin graft replacement for burns and acute wounds and ICX-TRC, a hair regeneration product.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report